Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.54T
24h Vol:
$9.62B
Dominance:
MSFT:5.17%
Stocklytics Platform
BETA
Instrument logo  ABBV

AbbVie Inc

ABBV
58 / 100
S&P500
$178.81arrow_drop_up0.40%$0.72

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

AbbVie Inc (ABBV) Stocklytics Forecast

AbbVie Inc (ABBV) is a global pharmaceutical company that specializes in research, development, and commercialization of advanced therapies in several therapeutic areas. With a diverse portfolio of products, AbbVie is known for its innovative and life-saving medications. In recent years, the company has experienced significant growth and has become a key player in the healthcare industry.

When looking at the stock price forecast for AbbVie Inc, it is important to consider various factors that can influence the future performance of the company. One major factor is the company's pipeline of new drugs and potential blockbuster products. AbbVie has a strong pipeline with several promising candidate drugs in various stages of development. If these drugs receive regulatory approval and successfully hit the market, it could have a positive impact on the company's stock price.

add AbbVie Inc to watchlist

Keep an eye on AbbVie Inc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
What is the analyst price prediction for AbbVie Inc (ABBV) stock?

Analysts have set a target price of $174.11 for AbbVie Inc (ABBV), based on forecasts from 19 analysts. The predicted price range extends from a high of $196 to a low of $150. This represents a potential increase of up to 9.61% and a decrease of -16.11% from the current price of $178.81. These forecasts are as of 2023 Feb 10.

question_mark
What are the analyst ratings for AbbVie Inc (ABBV) stock?

The analyst ratings for AbbVie Inc (ABBV) are distributed as follows: 10 analysts recommend buying, 10 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering AbbVie Inc.

question_mark
What is the AI price prediction for AbbVie Inc (ABBV) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that AbbVie Inc (ABBV) stock could reach $179.07 by 2024 Feb 29. This prediction indicates a potential price change of 0.15%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Feb 01.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.